Systemic BCG ‐osis following intravesical BCG instillation for bladder carcinoma
Author(s) -
Liaw Frank,
Tan Yan Yu,
Hendry David
Publication year - 2017
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.1129
Subject(s) - medicine , bladder cancer , immunotherapy , bcg vaccine , bladder tumor , urology , cancer immunotherapy , cancer , immunology , vaccination
Key Clinical Message Intravesical instillation of Bacillus Calmette‐Guérin ( BCG ) has been shown to be an effective form of immunotherapy for bladder cancer. This case report describes a patient who develops systemic BCG ‐osis following intravesical BCG instillation and demonstrates the importance of being aware of more severe complications associated with BCG immunotherapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom